Integer Holdings Corp
No SEC Form 4 filings for $ITGR in the last 30 days.
See all $ITGR insider activity →KKR will acquire medical device outsourcing company Integer Holdings in an all-cash deal valued at about $5.7 billion, paying $127 per share and assuming Integer’s outstanding debt, according to the companies. The offer implies a 4.78% premium to Integer’s Friday close. Integer shares rose 2.4% premarket. KKR said it will expand its healthcare portfolio.
Macquarie said global biotech funding for the year through Aug. 7 rose 75% YoY, driven by IPOs up 235% and follow-ons up 138%. The XBI biotech index gained 7% in the week to Aug. 7. Braveheart Bio’s upsized IPO raised $382.5M and shares jumped 66%. Curium agreed to buy Lantheus for up to $8B, and Supernus and Indivior plan an all-stock merger.
Integer Holdings (ITGR) agreed to be acquired by KKR in an all-cash deal valuing the company at about $5.7B. The offer is $127 per share. ITGR shares closed at $125.27 and have risen sharply since the bid. Simply Wall St cites a fair value of $112.14 (consensus target) and notes a DCF fair value of $169.74, with analyst targets ranging $95 to $127.
Over the past 7 days, alphai's AI scored 3 news stories mentioning ITGR (Integer Holdings Corp). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent ITGR coverage spans mergers & acquisitions and corporate actions.
Cash offer with a stated per-share price is a primary valuation catalyst for ITGR and should drive deal-arb dynamics.
A large all-cash take-private at a big premium is a classic spread trade for ITGR, with risk focused on deal completion.
The KKR all-cash bid creates a clear deal-price anchor, but the article flags valuation-model disagreement that can drive spread volatility and risk pricing.
Integer is the primary target of a take-private offer, creating a spread and deal-certainly trading setup.
The $127 all-cash acquisition price and definitive merger agreement are a direct catalyst for ITGR, shifting the stock toward deal-arb dynamics and reducing fundamental uncertainty near-term.
alphai scores every news story that mentions ITGR with an AI model for sentiment and relevance, and aggregates insider trades from Integer Holdings Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
KKR will acquire medical device outsourcing company Integer Holdings in an all-cash deal valued at about $5.7 billion, paying $127 per share and assuming Integer’s outstanding debt, according to the companies. The offer implies a 4.78% premium to Integer’s Friday close. Integer shares rose 2.4% premarket. KKR said it will expand its healthcare portfolio.
4 min readMacquarie said global biotech funding for the year through Aug. 7 rose 75% YoY, driven by IPOs up 235% and follow-ons up 138%. The XBI biotech index gained 7% in the week to Aug. 7. Braveheart Bio’s upsized IPO raised $382.5M and shares jumped 66%. Curium agreed to buy Lantheus for up to $8B, and Supernus and Indivior plan an all-stock merger.
6 min readInteger Holdings (ITGR) agreed to be acquired by KKR in an all-cash deal valuing the company at about $5.7B. The offer is $127 per share. ITGR shares closed at $125.27 and have risen sharply since the bid. Simply Wall St cites a fair value of $112.14 (consensus target) and notes a DCF fair value of $169.74, with analyst targets ranging $95 to $127.
7 min readKKR agreed to buy Integer Holdings for about $5.7B in an all-cash deal, taking Integer private. The transaction is expected to close before year-end, subject to regulatory approvals and shareholder support. Integer stockholders would receive about $127 per share, a 51%+ premium to April 29. Integer reported $464M Q2 sales, down 2.6%.
4 min readInteger Holdings Corp said it will be acquired in an all-cash merger by Armstrong Parent and Armstrong Bidco, affiliates of KKR. The offer price is $127 per share, with committed equity and debt financing and no financing condition. Closing is subject to regulatory and stockholder approvals, and Integer will become a wholly owned subsidiary.
1 min readInteger Holdings Corp (ITGR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 dp251220_ex0201.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER dated as of August 2, 2026 among INTEGER HOLDINGS CORPORATION, ARMSTRONG PARENT, INC. and ARMSTRONG BIDCO, INC. TABLE OF CONTENTS Page Article 1 Definitions Section 1.01. Definitio
3 min readKKR will take Integer Holdings private in an all-cash US$5.7bn deal, paying US$127 per share plus assuming Integer’s outstanding debt. The offer is a 4.78% premium. Integer makes components for medical devices in cardiovascular and neuromodulation. KKR said the deal should close by year-end, expanding its healthcare exposure.
3 min readInteger Holdings (ITGR) shares rose 2.7% after the company agreed to an all-cash acquisition by KKR valued at about $5.7 billion. The deal values ITGR at $127 per share. Integer also reported Q2 adjusted EPS of $1.60 and revenue of $464.1 million, both above expectations, and withdrew prior guidance and canceled its earnings call.
3 min readInteger Holdings (NYSE: ITGR) agreed to be acquired by KKR in an all-cash deal valued at about $5.7 billion. Integer shareholders will receive $127 per share, a 51.8% premium to the April 29 close and 28.8% to the July 31 30-day VWAP. Expected close by end-2026, subject to approvals. ITGR withdrew guidance and will not hold its Q2 call.
4 min readInteger Holdings (ITGR) said its board unanimously approved KKR’s offer to acquire the company for $127 per share, a 51.8% premium to its April 29, 2026 close. Integer withdrew prior guidance after reporting Q2 adjusted EPS of $1.60 on revenue of $464.1 million. The deal is expected to close by year-end.
5 min read
